The Reasoning Paradox: Why Training AI to "Think" Might Be Hurting Clinical Prediction

In the high-stakes world of medical artificial intelligence, a prevailing dogma has long suggested that if a model explains its reasoning, it will necessarily reach a more accurate conclusion. By training Large Language Models (LLMs) to provide a "rationale" before delivering a medical prognosis—a process known as Supervised Fine-Tuning (SFT) with synthetic rationales—researchers have assumed they were building more robust, transparent, and trustworthy clinical tools.

However, a groundbreaking study published on arXiv (v2, October 20, 2026) by Buxin Su and colleagues has upended this assumption. In a large-scale, rigorous experiment involving the prediction of Alzheimer’s disease and related dementias (ADRD), the researchers discovered that forcing models to generate "reasoning" before making a prediction consistently and significantly degrades performance. This study, which has sent ripples through the medical AI community, suggests that the current trend of "Chain-of-Thought" (CoT) fine-tuning for clinical tasks may be fundamentally flawed.

The Chronology of the Discovery

The journey toward this realization began in early 2026, as the researchers sought to improve longitudinal health history analysis.

June 9, 2026: The initial version of the paper was submitted, outlining the experimental framework. The team aimed to evaluate whether synthetic rationales—generated by high-performing models—could act as a "teaching signal" for smaller models tasked with predicting ADRD over a five-year horizon.
Summer 2026: Throughout the intervening months, the team conducted an exhaustive series of experiments, testing 504 distinct model configurations. They expanded their scope to include different model architectures and varying data scales, attempting to find a configuration where rationale-first training would yield superior results.
October 20, 2026: The finalized second version of the paper was published, detailing the surprising consistency of the negative results. The team also included a validation study on cardiovascular disease (CVD) prediction, confirming that the failure was not an isolated phenomenon specific to Alzheimer’s research.

Supporting Data: The Scale of the Failure

The study’s methodology was designed to be ironclad. By utilizing 504 experimental configurations, the researchers effectively neutralized the possibility that their findings were the result of a specific model’s quirks or a single data bottleneck.

The Rationale-First Degradation

The core finding is counterintuitive: when a model is fine-tuned to output a rationale before a prediction (Rationale-First SFT), its ability to correctly identify patient outcomes drops significantly compared to models trained on "Label Only" (where the model is asked to predict the outcome directly without the preceding explanation).

This degradation was not marginal; it was substantial. Whether the models were compact, specialized, or massive, general-purpose LLMs, the "rationale-first" constraint acted as a performance anchor. Even when the base models were explicitly designed for reasoning tasks, the negative impact persisted.

The Human Validation Paradox

A critical question arose: was the model failing because its rationales were "hallucinations" or medically unsound? The researchers employed human expert clinicians to evaluate the generated rationales. The results were striking: the rationales were deemed medically accurate and faithfully grounded in patient-specific evidence. The models were "thinking" correctly, but the process of articulating that thought was actively undermining their ability to finalize the diagnosis.

The "Label-Ordering" Intervention

Perhaps the most revealing piece of data came from a simple structural change. When the researchers flipped the output order—placing the prediction before the rationale—the performance degradation disappeared. The model regained its predictive accuracy while still producing a high-quality rationale. This suggests that the issue is not the existence of the reasoning, but the sequence of the generation.

Implications for Clinical AI Development

The implications of this study are profound, challenging the "interpretability-at-all-costs" mindset currently dominating AI healthcare policy.

Rethinking Chain-of-Thought

For years, the industry has pushed for Chain-of-Thought prompting as the gold standard for clinical AI transparency. This research suggests that while CoT is excellent for inference-time demonstrations (where the model is shown an example of good reasoning), it is a dangerous strategy for training targets. When a model is trained to condition its prediction on a generated rationale, it appears to introduce an error propagation mechanism—the model becomes overly sensitive to its own internal narrative, leading to a loss of accuracy.

The Bias of Conditioning

The "Label-Ordering" intervention implies that when a model is forced to generate a rationale first, it may be "anchoring" itself to the logic it just produced. If a model generates a rationale that is statistically probable but clinically peripheral, it then feels "locked in" to that path, potentially ignoring subtler, high-signal data points in the patient history that might have otherwise led to the correct prediction.

A Call for Precision in Clinical Design

The study serves as a warning against "one-size-fits-all" training protocols. Developers of high-stakes clinical AI can no longer assume that adding interpretability features (rationales) comes for free. The trade-off between transparency and accuracy is real, and for now, it appears that forcing a model to "show its work" during the training phase may be counterproductive to the primary goal: saving lives through accurate diagnosis.

Official Responses and Industry Outlook

The AI research community has reacted with a mix of surprise and reflection. Dr. Buxin Su’s findings have already prompted discussions in major AI labs regarding the shift from "Rationale-First" training to "Label-First" architectural design.

"We aren’t saying that rationales are useless," Su noted in the discussion of the paper. "On the contrary, we proved that when used as demonstrations during inference, these rationales help the model. But we must be careful not to conflate ‘explainability’ with ‘supervision.’ Teaching a model to explain its thoughts is a separate task from teaching it to reach a correct diagnosis."

Expert Perspectives

Medical AI ethicists have praised the study for its focus on the potential risks of "performative transparency." If a model produces a perfect, human-readable rationale that leads to a wrong diagnosis, it is arguably more dangerous than a "black-box" model that reaches the correct conclusion but cannot explain why. The study highlights the danger of creating systems that are "confident and articulate" but fundamentally less accurate.

Moving Forward

As we move into 2027, the focus of clinical AI research is expected to pivot toward:

Post-hoc Explainability: Separating the predictive task from the explanatory task, ensuring that the model does not "condition" its prediction on a potentially flawed internal narrative.
Inference-Time Rationale Injection: Leveraging the power of rationales by using them as prompts rather than training targets.
Rigorous Clinical Benchmarking: Moving beyond standard performance metrics to include "clinical utility" assessments, ensuring that AI tools function safely in the messy, longitudinal reality of patient care.

The study by Su et al. acts as a sobering reminder that in medicine, the goal is not just to build a model that sounds like a doctor, but to build a model that performs like one. For now, it seems the best way to get the right answer is to ask for the answer first—and leave the explanation for after the diagnosis has been rendered. The era of blind faith in Chain-of-Thought training is officially over, replaced by a new, more cautious mandate for data-driven precision in medical AI.